Showing results (321-330 of 1,750) with videos related to
Sort By:
Pageof 175
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2012
PD-1 blockade augments Th1 and Th17 and suppresses Th2 responses in peripheral blood from patients with prostate and advanced melanoma cancerJohn Dulos, Gregory J Carven, Susan J van Boxtel, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2012
Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4Dawn M Holt, Xinrong Ma, Namita Kundu, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 10, 2011
Cancer testis antigen, ropporin, is a potential target for multiple myeloma immunotherapyMaurizio Chiriva-Internati, Leonardo Mirandola, Yuefei Yu, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2011
Health-related quality of life before and during adjuvant interferon-α treatment for patients with malignant melanoma (DeCOG-trial)Susanne Ziefle, Friederike Egberts, Sarah Heinze, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2011
Assessment of ovarian function after preparative chemotherapy and total body radiation for adoptive cell therapyRussell C Langan, Peter A Prieto, Richard M Sherry, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2011
Multipotent mesenchymal stromal cells express FoxP3: a marker for the immunosuppressive capacity?Mikael Sundin, Pádraig D'arcy, C Christian Johansson, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2011
Decreased IL-7 signaling in T cells from patients with PTLD after allogeneic HSCTHamdy Omar, Raija Ahmed, Lalit Rane, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 11, 2011
Chimeric Trop2 virus-like particles: a potential immunotherapeutic approach against pancreatic cancerRafael Cubas, Sheng Zhang, Min Li, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 17, 2012
A novel HLA-A2-restricted CTL epitope of tumor-associated antigen L6 can inhibit tumor growth in vivoShih-Hsin Tu, Hsing-I Huang, Su-I Lin, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 17, 2012
EBV Latency II-derived peptides induce a specific CD4+ cytotoxic T-cell activity and not a CD4+ regulatory T-cell responseOlivier Moralès, Stéphane Depil, Dhafer Mrizak, et al.Pageof 175